Informações:
Falhas:
ID
19744
Descrição
A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT00300885
Link
https://clinicaltrials.gov/show/NCT00300885
Palavras-chave
Versões (1)
- 25/01/2017 25/01/2017 -
Transferido a
25 de janeiro de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Carcinoma, Non-Small Cell Lung NCT00300885
Eligibility Carcinoma, Non-Small Cell Lung NCT00300885
- StudyEvent: Eligibility
Similar models
Eligibility Carcinoma, Non-Small Cell Lung NCT00300885
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Non-Small Cell Lung Carcinoma TNM clinical staging Effusion | Non-Small Cell Lung Carcinoma TNM clinical staging
Item
stage iiib (with effusion) or stage iv nsclc any histology
boolean
C0007131 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C0013687 (UMLS CUI [1,3])
C0007131 (UMLS CUI [2,1])
C3258246 (UMLS CUI [2,2])
C3258246 (UMLS CUI [1,2])
C0013687 (UMLS CUI [1,3])
C0007131 (UMLS CUI [2,1])
C3258246 (UMLS CUI [2,2])
Chemotherapy
Item
no prior chemotherapy
boolean
C0392920 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status of 0 or 1
boolean
C1520224 (UMLS CUI [1])
Age
Item
greater than or equal to 18 years of age
boolean
C0001779 (UMLS CUI [1])
Life Expectancy
Item
life expectancy at least 12 weeks
boolean
C0023671 (UMLS CUI [1])
Bone Marrow function | Liver function | Renal function
Item
adequate bone marrow, liver and renal function
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
cancer treatment Systemic
Item
prior systemic anti cancer therapy
boolean
C0920425 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C0205373 (UMLS CUI [1,2])
Metastatic malignant neoplasm to brain | Neurologic Symptoms CT of brain | MRI brain procedure
Item
known brain metastasis. patients with neurological symptoms should undergo at computed tomography (ct) scan/magnetic resonance imaging (mri) of the brain to exclude brain metastasis
boolean
C0220650 (UMLS CUI [1])
C0235031 (UMLS CUI [2,1])
C0412585 (UMLS CUI [2,2])
C0412675 (UMLS CUI [3])
C0235031 (UMLS CUI [2,1])
C0412585 (UMLS CUI [2,2])
C0412675 (UMLS CUI [3])
Pulmonary hemorrhage CTCAE Grades
Item
pulmonary hemorrhage/bleeding event > common terminology criteria for adverse events (ctcae) grade 2 within 4 weeks of first dose of study drug
boolean
C0151701 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,2])
Thrombosis | Embolism | Transient Ischemic Attack
Item
thrombotic or embolic events including transient ischemic attack (tia) within the past 6 months
boolean
C0040053 (UMLS CUI [1])
C0013922 (UMLS CUI [2])
C0007787 (UMLS CUI [3])
C0013922 (UMLS CUI [2])
C0007787 (UMLS CUI [3])
Uncontrolled hypertension
Item
uncontrolled hypertension
boolean
C1868885 (UMLS CUI [1])
Hemorrhage CTCAE Grades
Item
any other hemorrhage/bleeding event > ctcae grade 3 within 4 weeks of first dose of study drug
boolean
C0019080 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,2])
major surgery
Item
major surgery within 4 weeks
boolean
C0679637 (UMLS CUI [1])
Bleeding tendency | Blood Coagulation Disorder
Item
evidence or history of bleeding diathesis or coagulopathy
boolean
C1458140 (UMLS CUI [1])
C0005779 (UMLS CUI [2])
C0005779 (UMLS CUI [2])